Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
After finishing at $3.03 in the prior trading day, Rocket Pharmaceuticals Inc (NASDAQ: RCKT) closed at $3.05, up 0.66%. In other words, the price has increased by $0.66 from its previous closing price. On the day, 1.43 million shares were traded. RCKT stock price reached its highest trading level at $3.15 during the session, while it also had its lowest trading level at $3.035.
Ratios:
Our goal is to gain a better understanding of RCKT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.39 and its Current Ratio is at 6.39. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On May 30, 2025, Evercore ISI Downgraded its rating to In-line which previously was Outperform but kept the price unchanged to $5.
Morgan Stanley Downgraded its Overweight to Equal-Weight on May 28, 2025, while the target price for the stock was maintained at $7.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 14 ’25 when Militello John bought 7,043 shares for $3.02 per share.
Wilson Martin bought 12,109 shares of RCKT for $36,553 on Aug 14 ’25. On Aug 14 ’25, another insider, Schwartz Jonathan David, who serves as the Officer of the company, bought 11,161 shares for $3.02 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RCKT now has a Market Capitalization of 329107200 and an Enterprise Value of 82814808.
Stock Price History:
The Beta on a monthly basis for RCKT is 0.62, which has changed by -0.8411458 over the last 52 weeks, in comparison to a change of 0.15005577 over the same period for the S&P500. Over the past 52 weeks, RCKT has reached a high of $22.01, while it has fallen to a 52-week low of $2.19. The 50-Day Moving Average of the stock is 3.08%, while the 200-Day Moving Average is calculated to be -62.88%.
Shares Statistics:
The stock has traded on average 4.86M shares per day over the past 3-months and 2247660 shares per day over the last 10 days, according to various share statistics. A total of 107.88M shares are outstanding, with a floating share count of 98.96M. Insiders hold about 8.43% of the company’s shares, while institutions hold 85.57% stake in the company. Shares short for RCKT as of 1753920000 were 11233730 with a Short Ratio of 2.31, compared to 1751241600 on 13582989. Therefore, it implies a Short% of Shares Outstanding of 11233730 and a Short% of Float of 20.28.
Earnings Estimates
The dynamic stock of Rocket Pharmaceuticals Inc (RCKT) is currently attracting attention from 14.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.46, with high estimates of -$0.33 and low estimates of -$0.61.
Analysts are recommending an EPS of between -$0.89 and -$2.36 for the fiscal current year, implying an average EPS of -$2.05. EPS for the following year is -$1.12, with 14.0 analysts recommending between $1.76 and -$2.13.
